- Home
- HUBS vs TEVA Comparison
HUBS vs TEVA Comparison
Compare HUBS & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUBS | TEVA |
|---|---|---|
| Founded | 2005 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8B | 30.2B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | HUBS | TEVA |
|---|---|---|
| Price | $377.40 | $28.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 30 | 8 |
| Target Price | ★ $626.87 | $27.00 |
| AVG Volume (30 Days) | 833.8K | ★ 11.4M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | $2,987,698,000.00 | ★ $16,776,000,000.00 |
| Revenue This Year | $20.84 | $4.74 |
| Revenue Next Year | $16.03 | $0.48 |
| P/E Ratio | ★ N/A | $46.12 |
| Revenue Growth | ★ 19.21 | 0.02 |
| 52 Week Low | $344.41 | $12.47 |
| 52 Week High | $881.13 | $28.68 |
Technical Indicators
Market Signals| Indicator | HUBS | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 41.61 | 80.93 |
| Support Level | $364.00 | $24.01 |
| Resistance Level | $381.70 | $26.96 |
| Average True Range (ATR) | 13.79 | 0.68 |
| MACD | 4.30 | 0.19 |
| Stochastic Oscillator | 67.68 | 94.65 |
Price Performance
Historical ComparisonAbout HUBS HubSpot Inc.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.